Lung cancer pill cuts risk of death by half, says study
[…] Taking the drug osimertinib after surgery dramatically reduced the risk of patients dying by 51%, results presented at the world’s largest cancer conference showed. […] “Fifty per cent is a big deal in any disease, but certainly in a disease like lung cancer, which has typically been very resistant to therapies.” The Adaura trial Read more about Lung cancer pill cuts risk of death by half, says study[…]